Login to Your Account

HGSI, GSK Seal Deal, Settle on $14.25 per Share; $3.6B Value

By Marie Powers
Staff Writer

Tuesday, July 17, 2012
After mulling its options for three months, Human Genome Sciences Inc. accepted a sweetened proposal from GlaxoSmithKline plc, agreeing to a union that most industry observers expected all along.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription